ANI Pharmaceuticals (ANIP) PT Lowered to $30 at Cantor Fitzgerald, Following Earnings
Tweet
Share
E-mailGet Alerts ANIP Hot Sheet
Price: $76.00 -0.71%
Rating Summary:
10 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
10 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Cantor Fitzgerald analyst Brandon Folkes lowered the price target on ANI Pharmaceuticals (NASDAQ: ANIP) to $30.00 (from $40.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Enovix Corporation (ENVX) PT Lowered to $5 at BofA Securities
- argenx SE (ARGX) PT Raised to $1,353 at TD Cowen
- ANI Pharmaceuticals (ANIP) PT Lowered to $119 at Guggenheim
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Cantor Fitzgerald, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
